Yuka Yamagishi
Overview
Explore the profile of Yuka Yamagishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
245
Citations
1322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito Y, Yamagishi T, Ikenoue C, Ishiwada N, Ito K, Iwatani S, et al.
Pediatr Infect Dis J
. 2024 Dec;
44(3):e90-e94.
PMID: 39714794
Congenital syphilis (CS) is a mother-to-child infection caused by the bacterium Treponema pallidum , transmitted through the placenta. In Japan, the number of syphilis cases has recently increased, accompanied by...
2.
Yagi Y, Yanagisawa N, Higuchi S, Okazaki M, Kawada K, Ishida T, et al.
J Infect Chemother
. 2024 Sep;
31(1):102528.
PMID: 39313149
Objectives: To evaluate the efficacy and patient outcomes of pharmacist-physician collaborative protocol-based antimicrobial treatment regimens for antimicrobial stewardship. Methods: Patients treated for aspiration pneumonia due to stroke within 48 h...
3.
Yamagishi Y, Nakamura N, Minami M, Keyama K, Osaka K, Maeda N, et al.
J Infect Chemother
. 2024 Sep;
31(2):102527.
PMID: 39307418
Introduction: Despite its importance for young women, the human papillomavirus (HPV) vaccination coverage remains low in Japan. Previous studies have examined behaviors related to HPV catch-up vaccination. Uniquely, this study...
4.
Yagi Y, Yamagishi Y, Hamada Y
Med Mycol J
. 2024 Sep;
65(3):59-65.
PMID: 39218648
Chronic pulmonary aspergillosis (CPA) represents a spectrum of lung disorders caused by local proliferation of Aspergillus hyphae in individuals with non-systemic or mildly systemic immunodepression or altered pulmonary integrity due...
5.
Arakawa Y, Yagi Y, Mimoto A, Nishida Y, Kuwana S, Nakai E, et al.
Cureus
. 2024 Jul;
16(6):e62744.
PMID: 39036232
inhabits the gingival sulcus and has been reported to cause various periodontal diseases; it has rarely been reported to cause bacteremia. We describe a case of a two-year-old boy who...
6.
Itadani K, Oonishi Y, Hisada H, Tanaka T, Mizunaga S, Yamagishi Y, et al.
Jpn J Infect Dis
. 2024 Jun;
77(6):334-341.
PMID: 38945858
The widespread prevalence of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli limits treatment options and is a worldwide problem. This study aimed to investigate the antimicrobial susceptibility and ESBL types of 204...
7.
Yagi Y, Doke A, Iwame S, Arakawa Y, Yamagishi Y
Infect Drug Resist
. 2024 Jun;
17:2237-2247.
PMID: 38854779
Background: Methicillin-resistant (MRSA) enteritis is a condition in which MRSA grows abnormally in the intestine after administration of antimicrobial agents, resulting in enteritis. Patients with MRSA detected in stool culture...
8.
Kunishima H, Ichiki K, Ohge H, Sakamoto F, Sato Y, Suzuki H, et al.
J Infect Chemother
. 2024 May;
30(8):673-715.
PMID: 38714273
No abstract available.
9.
Yamagishi Y, Nakayama N, Doke A, Iwame S, Nishida Y, Arakawa Y, et al.
J Infect Chemother
. 2024 May;
30(11):1128-1133.
PMID: 38697390
Objectives: An increasing number of drug-resistant bacteria have been identified recently. In particular, drug-resistant bacteria have been linked to unfavorable prognoses in patients with bacteremia, highlighting the need for rapid...
10.
Umemura T, Kato H, Asai N, Hagihara M, Hirai J, Yamagishi Y, et al.
Heliyon
. 2024 Apr;
10(8):e29811.
PMID: 38681574
Objectives: We performed a comprehensive systematic review and meta-analysis to evaluate the clinical or microbiological outcomes and safety of a combination of daptomycin (DAP) and β-lactams compared to DAP monotherapy...